VISUAL RESULTS OF 27-GUAGE TRANS-CONJUNCTIVAL SUTURELESS SURGICAL INTERVENTION IN DIABETIC VITREOUS HEMORRHAGE

Main Author: Dr Zafar Iqbal, Dr Maisa Al Sweilem, Dr Aswad Ahmed, Dr Sidra Zafar Iqbal, Dr Muhammad Saad Ullah
Format: Article eJournal
Terbitan: , 2019
Online Access: https://zenodo.org/record/3551351
Daftar Isi:
  • Objective: The purpose of this study is to assess the results of 17 trans-conjunctival surgical intervention and different complications and problem related to this procedure in the patients suffering from DVH (Diabetic Vitreous Hemorrhage). Methodology: This research work carried out on 70 patients present with the not controllable Type-2 diabetes appearing with the DVH. The most important measured outcome was the BCVA (Best Corrected Visual Acuity). We also screened the complication after the surgery at every visit. We carried out the follow ups at one day, 30 days, 3 months and 6 months after the surgery. Results: Out of 70 patients, 57.78% (n: 45) were male patients and 38.18% (n: 25) were female patients. The average age of the patients was 50.318 ± 4.578 years (93.0% CI: 53.130-55.570). For majority of the patients, there was improvement in the BCVA progressively with each succeeding visit of follow-up. BCVA before the surgery was 1.008 ± 0.204 Log-Mar in comparison with the BCVA at the very last visit of follow-up was 0.220 ± 0.229. 4.88% (n: 8) patients developed recurring DVH in the duration of this research work, 2.58% (n: 6) developed the complication of cataract, 1.8% (n: 1) were present with the raised intra-ocular pressure and sub-conjunctival hemorrhage was available in 2.28% (n: 2) patients. Conclusion: This particular type of surgery is very effectual type surgery without sutures with encouraging results regarding visual acuity, in the patients suffering from DVH. There are very complications associated with this procedure and the management of those complications is not much difficult. KEY WORDS: Visual Acuity, Complication, Hemorrhage, Ophthalmic, Outcome, Surgical Intervention, Retinopathy, Diabetes.